TY  - GEN
AU  - Hu,Bei
AU  - Thall,Peter
AU  - Milton,Denái R
AU  - Sasaki,Koji
AU  - Bashir,Qaiser
AU  - Shah,Nina
AU  - Patel,Krina
AU  - Popat,Uday
AU  - Hosing,Chitra
AU  - Nieto,Yago
AU  - Lin,Pei
AU  - Delgado,Ruby
AU  - Jorgensen,Jeffrey
AU  - Manasanch,Elisabet
AU  - Weber,Donna
AU  - Thomas,Sheeba
AU  - Orlowski,Robert Z
AU  - Champlin,Richard
AU  - Qazilbash,Muzaffar H
TI  - High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes
SN  - 1029-2403
PY  - 2020///0320
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - Chromosome Aberrations
KW  - Combined Modality Therapy
KW  - Cytogenetic Analysis
KW  - Female
KW  - Flow Cytometry
KW  - Genetic Predisposition to Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - diagnosis
KW  - Neoplasm, Residual
KW  - Prognosis
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1080/10428194.2018.1485908
ER  -